In my case, partly because my daughter is a GP, probably because of her input we received a lot more information than most patients. Because of my condition, endocarditis and a growth on the valve, a surgical procedure was opted for in preference to TAVR. The cardiac team informed me that the valve should last 10-20 years before requiring replacement. At a point where it does deteriorate sufficiently to require replacement a TAVR procedure, valve in valve, is the most likely option. Regular echos monitor the valves performance.
I've attached a peer reviewed paper to support my comments. Again, please correct me if I've posted anything untrue.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994436/
- Forums
- ASX - By Stock
- AVR
- Anteris Channel 9 Interview 2022
Anteris Channel 9 Interview 2022, page-33
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.71 |
Change
0.010(0.06%) |
Mkt cap ! $301.9M |
Open | High | Low | Value | Volume |
$16.00 | $16.01 | $15.49 | $3.254M | 230.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $15.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.20 | 700 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 15.700 |
1 | 437 | 15.550 |
1 | 296 | 15.510 |
2 | 1150 | 15.500 |
2 | 652 | 15.490 |
Price($) | Vol. | No. |
---|---|---|
16.200 | 700 | 2 |
16.500 | 63 | 1 |
16.600 | 500 | 1 |
17.000 | 550 | 1 |
17.100 | 900 | 1 |
Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |